Company news
Adaptive Biotechnologies Corporation news in 2019
Adaptive Biotechnologies Corporation's news releases, calls and decks from 2019, newest first.
Adaptive Biotechnologies to Present at the 38th Annual J.P. Morgan Healthcare Conference
December 29, 2019
Adaptive and AbbVie Partner Across Multiple Myeloma Trials to Measure Minimal Residual Disease Using the clonoSEQ® Assay
December 8, 2019
Adaptive Biotechnologies and Collaborators to Present Data from More Than 25 clonoSEQ® Abstracts at ASH 2019 Demonstrating Clinical Relevance of Standardized, Accurate MRD Testing for Blood Cancer Patients
December 3, 2019
Adaptive Biotechnologies Corporation Reports Third Quarter 2019 Financial Results
November 11, 2019
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 12, 2019
October 28, 2019
Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx
September 23, 2019
Adaptive Biotechnologies Enters Partnership for Use Of clonoSEQ® as Preferred MRD Test for Drug Development Across Amgen’s Hematology Franchise
September 16, 2019